These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 855998)

  • 1. Chemotherapy of an experimental Bacteroides fragilis infection in mice.
    Walker CB; Nitzan D; Wilkins TD
    Antimicrob Agents Chemother; 1977 Mar; 11(3):435-40. PubMed ID: 855998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
    Brook I
    Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clindamycin, metronidazole, and penicillin for the treatment of experimental infections in mice caused by beta-lactamase-producing Bacteroides intermedius.
    Cockerill FR; Rosenblatt JE; Lee DT; Gay JD
    Diagn Microbiol Infect Dis; 1986 May; 5(1):25-30. PubMed ID: 3486740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy and pharmacokinetic properties of rifampicin in a Bacteroides fragilis intra-abdominal abscess.
    Fu KP; Lasinski ER; Zoganas HC; Kimble EF; Konopka EA
    J Antimicrob Chemother; 1984 Dec; 14(6):633-40. PubMed ID: 6520063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis.
    Gollapudi SV; Gupta A; Thadepalli H; Perez A
    Infect Immun; 1988 Sep; 56(9):2369-72. PubMed ID: 3044996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
    Bartlett JG; Joiner KA; Dezfulian M; Marien GJ
    Rev Infect Dis; 1982; 4 Suppl():S664-9. PubMed ID: 6218580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penicillin failure in the treatment of Bacteroides fragilis lung abscess. Experimental study in rabbits.
    Thadepalli H; Kannangara DW; Bach VT
    Chemotherapy; 1983; 29(4):289-93. PubMed ID: 6872619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of bacteroides strains to tetracycline, chloramphenicol, doxycycline, and clindamycin.
    Monif GR; Baer H
    Obstet Gynecol; 1974 Feb; 43(2):211-4. PubMed ID: 4589458
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic therapy of endometritis following cesarean section. Treatment successes and failures.
    Gibbs RS; Jones PM; Wilder CJ
    Obstet Gynecol; 1978 Jul; 52(1):31-7. PubMed ID: 683627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of 10 antimicrobial agents in experimental infections with Bacteroides fragilis.
    Joiner K; Lowe B; Dzink J; Bartlett JG
    J Infect Dis; 1982 Apr; 145(4):561-8. PubMed ID: 7069236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
    Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
    J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous metronidazole therapy for Bacteroides fragilis meningitis.
    Bryan CS; Huffman LJ; Del Bene VE; Sanders CV; Scalcini MC
    South Med J; 1979 Apr; 72(4):494-7. PubMed ID: 373128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.
    Hackman AS; Wilkins TD
    Antimicrob Agents Chemother; 1975 Aug; 8(2):224-5. PubMed ID: 1180547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility of the subspecies of Bacteroides fragilis.
    Blazevic DJ
    Antimicrob Agents Chemother; 1976 Mar; 9(3):481-4. PubMed ID: 1259403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.
    Schoutens E; Van Beers D; Yourassowsky E
    Infection; 1974; 2(2):59-63. PubMed ID: 4367028
    [No Abstract]   [Full Text] [Related]  

  • 20. Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis.
    Bartlett JG; Dezfulian M; Joiner K
    Arch Surg; 1983 Feb; 118(2):181-4. PubMed ID: 6849635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.